58 related articles for article (PubMed ID: 12209693)
21. Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation.
Wang JQ; Jeelall YS; Ferguson LL; Horikawa K
Front Immunol; 2014; 5():367. PubMed ID: 25132836
[TBL] [Abstract][Full Text] [Related]
22. A review of the application of inflammatory biomarkers in epidemiologic cancer research.
Brenner DR; Scherer D; Muir K; Schildkraut J; Boffetta P; Spitz MR; Le Marchand L; Chan AT; Goode EL; Ulrich CM; Hung RJ
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1729-51. PubMed ID: 24962838
[TBL] [Abstract][Full Text] [Related]
23. Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia.
Yan XJ; Dozmorov I; Li W; Yancopoulos S; Sison C; Centola M; Jain P; Allen SL; Kolitz JE; Rai KR; Chiorazzi N; Sherry B
Blood; 2011 Nov; 118(19):5201-10. PubMed ID: 21911837
[TBL] [Abstract][Full Text] [Related]
24. Inflammation and survival pathways: chronic lymphocytic leukemia as a model system.
Chen LS; Balakrishnan K; Gandhi V
Biochem Pharmacol; 2010 Dec; 80(12):1936-45. PubMed ID: 20696142
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis.
Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Kulig A; Malecka-Panas E
Dig Dis Sci; 2009 Mar; 54(3):683-9. PubMed ID: 18661238
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous analysis of cytokines and co-stimulatory molecules concentrations by ELISA technique and of probabilities of measurable concentrations of interleukins IL-2, IL-4, IL-5, IL-6, CXCL8 (IL-8), IL-10, IL-13 occurring in plasma of healthy blood donors.
Martin K; Viera K; Petr C; Marie N; Eva T
Mediators Inflamm; 2006; 2006(5):65237. PubMed ID: 17392576
[TBL] [Abstract][Full Text] [Related]
27. The cancer stem cell: evidence for its origin as an injured autoreactive T cell.
Grandics P
Mol Cancer; 2006 Feb; 5():6. PubMed ID: 16478542
[TBL] [Abstract][Full Text] [Related]
28. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial.
Jatoi A; Egner J; Loprinzi CL; Sloan JA; Novotny PJ; Dakhil SR; Mailliard JA; Klee GG; Krook JE
Support Care Cancer; 2004 Sep; 12(9):640-4. PubMed ID: 15278681
[TBL] [Abstract][Full Text] [Related]
29. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.
Boonstra JG; von't Veer MB; Gratama JW
J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702
[TBL] [Abstract][Full Text] [Related]
30. Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.
Bairey O; Ruchlemer R; Rahimi-Levene N; Herishanu Y; Braester A; Berrebi A; Polliack A; Klepfish A; Shvidel L;
Ann Hematol; 2011 Oct; 90(10):1123-9. PubMed ID: 21614458
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
[TBL] [Abstract][Full Text] [Related]
33. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
[TBL] [Abstract][Full Text] [Related]
34. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
35. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
Gentile M; Mauro FR; Calabrese E; De Propris MS; Giammartini E; Mancini F; Milani ML; Guarini A; Foà R
Br J Haematol; 2005 Aug; 130(4):549-57. PubMed ID: 16098069
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters.
Hulkkonen J; Vilpo J; Vilpo L; Koski T; Hurme M
Haematologica; 2000 Jun; 85(6):600-6. PubMed ID: 10870116
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
